| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $3.84M | - | |
| CEO | 338.1K | $2.62M | - | |
| Other | 240.7K | $1.86M | - | |
| Other | 240.3K | $1.86M | - | |
| CFO | 147.1K | $1.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2017 | Vittal Vasista79 | Chief Financial Officer | Sell | 5,000 | $33.25 | $166,250.00 | -5.1% | |
| Oct 11, 2017 | Donald J Hayden Jr. | Director | Sale+OE | 20,000 | $34.95 | $699,000.00 | - | |
| Sep 27, 2017 | Donald J Hayden Jr. | Director | Sale+OE | 20,000 | $32.45 | $649,000.00 | - | |
| Sep 20, 2017 | Kenneth T. Mills81 | President and CEO | Sell | 10,000 | $29.33 | $293,273.00 | -8.4% | |
| Sep 18, 2017 | Donald J Hayden Jr. | Director | Sale+OE | 40,000 | $28.70 | $1,148,000.00 | - | |
| Sep 15, 2017 | Vittal Vasista79 | Chief Financial Officer | Sell | 5,000 | $27.39 | $136,925.26 | -4.9% | |
| Sep 8, 2017 | Stephen Yoo | Chief Medical Officer | Sale+OE | 27,342 | $25.00 | $683,550.00 | - | |
| Sep 6, 2017 | Stephen Yoo | Chief Medical Officer | Sale+OE | 32,658 | $25.00 | $816,450.00 | - | |
| Sep 5, 2017 | Kenneth T. Mills81 | President and CEO | Sell | 10,500 | $25.00 | $262,500.00 | -8.1% | |
| Sep 5, 2017 | Donald J Hayden Jr. | Director | Sale+OE | 20,000 | $24.95 | $499,000.00 | - |